Prospective study confirms contrast sensitivity benefits of IOL

February 1, 2004

Eugene, OR-Implantation of the anterior surface modified prolate IOL (Tecnis, Pfizer Ophthalmics) results in improved functional vision for cataract surgery patients compared with a standard spherical IOL, said Mark D. Packer, MD.